cadmium has been researched along with Parkinson Disease in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 4 (40.00) | 2.80 |
Authors | Studies |
---|---|
Horvath, I; Kumar, R; Lorentzon, E; Rodrigues, JI; Tamás, MJ; Wittung-Stafshede, P | 1 |
Abraham, KS; Ayyadurai, N; G, S; Giridharan, B; Gopalakrishnan, AV; Kumar, N; Mahalaxmi, I; Nachimuthu, SK; Narayanasamy, A; P, S; Pasha, MY; Rao, KRSS; Reddy, JK; Selvaraj, P; Suriyanarayanan, A; Vellingiri, B; Venkatesan, D; Winster, H | 1 |
Cheng, Y; Deng, P; Hao, R; He, H; Hong, H; Lin, X; Mao, G; Pi, H; Tong, T; Xu, Y; Yang, L; Yu, Z; Zhang, J; Zhou, Z | 1 |
Naeem, S; Qi, Y; Tian, Y; Zhang, Y | 1 |
Gu, Z; James, TD; Liu, FT; Long, YT; Ma, W; Pan, ZG; Qin, LX; Wang, J | 1 |
Aboud, AA; Bowman, AB; Erikson, KM; Ess, KC; Han, B; Hedera, P; Hong, CC; Kumar, KK; Neely, MD; Tidball, AM | 1 |
Ansari, NG; Garg, RK; Gupta, V; Khattri, S | 1 |
Chimedregzen, U; Kagawa, Y; Kaneko, Y; Kawabata, T; Komatsu, F; Otgon, J; Purvee, B | 1 |
Huang, CS; Kuo, CC; Pan, MK; Tai, CH; Yang, YC | 1 |
Brunetti, V; Cingolani, R; Curcio, A; Di Corato, R; George, C; Malvindi, MA; Melisi, D; Pellegrino, T; Ragusa, A; Rimoli, MG; Tino, A; Tortiglione, C | 1 |
1 review(s) available for cadmium and Parkinson Disease
Article | Year |
---|---|
Role of heavy metals (copper (Cu), arsenic (As), cadmium (Cd), iron (Fe) and lithium (Li)) induced neurotoxicity.
Topics: Arsenic; Cadmium; Copper; Humans; Iron; Lithium; Metals, Heavy; Neurotoxicity Syndromes; Parkinson Disease | 2022 |
9 other study(ies) available for cadmium and Parkinson Disease
Article | Year |
---|---|
Effects of the Toxic Metals Arsenite and Cadmium on α-Synuclein Aggregation In Vitro and in Cells.
Topics: alpha-Synuclein; Amyloid; Arsenites; Cadmium; Cell Line; Metals, Heavy; Neurodegenerative Diseases; Parkinson Disease; Saccharomyces cerevisiae | 2021 |
Chronic cadmium exposure induces Parkinson-like syndrome by eliciting sphingolipid disturbance and neuroinflammation in the midbrain of C57BL/6J mice.
Topics: Animals; Biomarkers; Cadmium; Ceramides; Chromatography, Liquid; Humans; Mesencephalon; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Parkinson Disease; RNA, Messenger; Sphingolipids; Sphingomyelins; Tandem Mass Spectrometry | 2023 |
NIX compensates lost role of parkin in cd-induced mitophagy in HeLa cells through phosphorylation.
Topics: Cadmium; HeLa Cells; Humans; Membrane Proteins; Mitophagy; Parkinson Disease; Phosphorylation; Proto-Oncogene Proteins; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases | 2020 |
Ubiquinone-quantum dot bioconjugates for in vitro and intracellular complex I sensing.
Topics: Biosensing Techniques; Cadmium; Electrochemical Techniques; Electron Transport; Electron Transport Complex I; Humans; Mitochondria; NAD; Oxidation-Reduction; Parkinson Disease; Quantum Dots; Respiration; Selenium; Ubiquinone; Zinc | 2013 |
PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.
Topics: Adult; Cadmium; Cell Line; Copper; Genetic Predisposition to Disease; Humans; Induced Pluripotent Stem Cells; Male; Manganese; Membrane Potential, Mitochondrial; Methylmercury Compounds; Mitochondria; Mutation; Neural Stem Cells; Parkinson Disease; Risk Factors; Ubiquitin-Protein Ligases | 2015 |
Determination of Cd, Cr, Pb and Ni contents among Parkinson's disease individuals: a case-control study.
Topics: Adult; Aged; Cadmium; Case-Control Studies; Chromium; Female; Humans; Lead; Male; Metals, Heavy; Middle Aged; Nickel; Parkinson Disease; Severity of Illness Index; Spectrophotometry, Atomic; Statistics as Topic | 2017 |
A high accumulation of hair minerals in Mongolian people: 2(nd) report; influence of manganese, iron, lead, cadmium and aluminum to oxidative stress, Parkinsonism and arthritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aluminum; Arthritis; Cadmium; Case-Control Studies; Child; Female; Hair; Humans; Iron; Japan; Lead; Male; Manganese; Middle Aged; Minerals; Mongolia; Oxidative Stress; Parkinson Disease; Poaceae; Prevalence; Soil; Water; Young Adult | 2011 |
Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease.
Topics: Animals; Benzimidazoles; Cadmium; Calcium; Calcium Channels, T-Type; Cyclopropanes; Dihydropyridines; Disease Models, Animal; Electrophysiology; Male; Mibefradil; Movement; Naphthalenes; Neurons; Nickel; Nitrophenols; Organophosphorus Compounds; Parkinson Disease; Rats; Rats, Wistar | 2011 |
Multiple functionalization of fluorescent nanoparticles for specific biolabeling and drug delivery of dopamine.
Topics: Attention Deficit Disorder with Hyperactivity; Cadmium; Cadmium Compounds; Cell Line, Tumor; Dopamine; Dopamine Agents; Drug Delivery Systems; Fluorescent Dyes; Glucose Transporter Type 1; Humans; Parkinson Disease; Polyethylene Glycols; Quantum Dots; Selenium; Staining and Labeling; Sulfides | 2011 |